REPLIMUNE GROUP INC
REPL · NASDAQ
Updated at 2026-10-15 08:00:17
- Today's High
- $12.37
- Today’s Low
- $11.37
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $12.05
- Previous Close
- $11.39
- Volume
- 1.86M
- Market Cap
- $1.07B
- P/E Ratio
- --
- EPS
- $-3.15
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 500 UNICORN PARK DRIVE, WOBURN, MA, UNITED STATES, 01801
- Country
- US
- Listing Date
- 2018-07-20
- Fiscal Year End
- March
- Shares Outstanding
- 84.03M
- CIK
- 0001737953
- Website
- www.replimune.com
Replimune Group, Inc., a biotechnology company, develops oncolytic immunogenic therapies to treat cancer. The company is headquartered in Woburn, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$68.24M
2026-03-31
$73.33M
2025-12-31
$71.86M
2025-09-30
$84.29M
Net Income
2026-06-30
-$69.76M
2026-03-31
-$73.21M
2025-12-31
-$70.93M
2025-09-30
-$83.1M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.72
2026-03-31
$-0.76
2025-12-31
$-0.77
2025-09-30
$-0.90
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$66.02M
2026-03-31
-$70.72M
2025-12-31
-$68.75M
2025-09-30
-$81.74M
Effective Tax Rate
2026-06-30
0.42%
2026-03-31
0.32%
2025-12-31
0.43%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $68.24M | $73.33M | $71.86M | $84.29M |
| Net Income | -$69.76M | -$73.21M | -$70.93M | -$83.1M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.72 | $-0.76 | $-0.77 | $-0.90 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$66.02M | -$70.72M | -$68.75M | -$81.74M |
| Effective Tax Rate | 0.42% | 0.32% | 0.43% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.